Hyperion DeFi (NASDAQ:HYPD) Shares Down 11.5% – Should You Sell?

Hyperion DeFi, Inc. (NASDAQ:HYPD)’s share price dropped 11.5% on Monday . The stock traded as low as $3.03 and last traded at $3.08. Approximately 326,686 shares changed hands during mid-day trading, an increase of 11% from the average daily volume of 293,538 shares. The stock had previously closed at $3.48.

Analyst Ratings Changes

Several equities research analysts recently commented on HYPD shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperion DeFi in a research note on Wednesday, October 8th. Wall Street Zen raised Hyperion DeFi from a “sell” rating to a “hold” rating in a research report on Saturday, November 22nd. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Reduce” and an average price target of $2.00.

Hyperion DeFi Stock Performance

The company has a market cap of $25.16 million, a PE ratio of -0.76 and a beta of 2.81. The stock’s 50 day simple moving average is $5.75 and its two-hundred day simple moving average is $7.55. The company has a quick ratio of 2.25, a current ratio of 2.25 and a debt-to-equity ratio of 0.11.

Hyperion DeFi (NASDAQ:HYPD) last released its quarterly earnings data on Friday, November 14th. The company reported $0.05 EPS for the quarter. The business had revenue of $0.36 million during the quarter. Hyperion DeFi had a negative return on equity of 119.59% and a negative net margin of 62,238.41%. As a group, research analysts anticipate that Hyperion DeFi, Inc. will post -41.6 earnings per share for the current year.

Hedge Funds Weigh In On Hyperion DeFi

An institutional investor recently bought a new position in Hyperion DeFi stock. Virtu Financial LLC purchased a new position in shares of Hyperion DeFi, Inc. (NASDAQ:HYPD) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 23,065 shares of the company’s stock, valued at approximately $25,000. Virtu Financial LLC owned 0.82% of Hyperion DeFi at the end of the most recent quarter. Institutional investors own 25.84% of the company’s stock.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.